mProX™ Human P2RX4 Stable Cell Line
- Product Category:
- Membrane Protein Stable Cell Lines
- Subcategory:
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
Made to Order Inquiry
InquiryProduct Information
Product Properties
Protocols
Please visit our protocols page.
Customer Reviews
There are currently no Customer reviews or questions for mProX™ Human P2RX4 Stable Cell Line (S01YF-1023-PY255). Click the button above to contact us or submit your feedback about this product.
Jordan Miller (Verified Customer)
Patrick Liam (Creative Biolabs Scientific Support)
Taylor Brown (Verified Customer)
Patrick Liam (Creative Biolabs Scientific Support)
Published Data
Fig.1 Knockdown p2rx4 in BV-2 cells.
In the transfection process, a reduction in P2X4R expression of 68% and 62% was achieved in Microglial BV-2 cells when they were transinfected with LV-shRNA-p2rx4, as compared to cells that were not treated (NT) and those treated solely with LV.
Ref: Khoja, Sheraz, et al. "Reduced expression of purinergic P2X4 receptors increases voluntary ethanol intake in C57BL/6J mice." Alcohol 68 (2018): 63-70.
Pubmed: 29477921
DOI: 10.1016/j.alcohol.2017.09.004
Research Highlights
Pang, Xiaoao. et al. "Coordination of Single-cell and Bulk RNA Sequencing to Construct a Cuproptosis-related Gene Prognostic Index for Endometrial Cancer Prognosis, Immune Microenvironment Infiltration, and Immunotherapy Treatment Options." Journal of Cancer, 2023.
This article examines the concept of procrastination in relation to academic performance. It explores the various factors that contribute to procrastination and its potential impact on students' academic success. The study also investigates the coping strategies employed by students to overcome procrastination. Results suggest that procrastination is a prevalent issue among students and can have significant consequences on their academic achievements. The findings highlight the importance of addressing procrastination in educational settings and suggest potential interventions to improve academic performance.
Pang, Xiaoao. et al. "Coordination of Single-cell and Bulk RNA Sequencing to Construct a Cuproptosis-related Gene Prognostic Index for Endometrial Cancer Prognosis, Immune Microenvironment Infiltration, and Immunotherapy Treatment Options." Journal of Cancer, 2023.
Pubmed:
37859813
DOI:
10.7150/jca.86325
Zhou, Chufan. et al. "The inflammatory response-related robust machine learning signature in endometrial cancer: Based on multi-cohort studies." The journal of gene medicine, 2023.
Uterine corpus endometrial carcinoma (UCEC) is a common cancer affecting women, characterized by abnormal cell growth in the inner lining of the uterus. Inflammation is a key factor in the progression and outcomes of UCEC, thus identifying inflammatory response-related subtypes is crucial for personalized treatment. This research identified significant differences in immune response among UCEC tumors based on molecular subtypes of inflammatory response-related genes. Subtype A showed a more favorable prognosis and was more responsive to immunotherapies. Further analysis revealed subtype-specific variations in immune response and sensitivity to chemotherapy. A 12-gene signature was also identified as a prognostic marker for UCEC patients. A validated machine learning-based signature also highlighted important clinical distinctions between low and high-risk groups. These differences included increased infiltration of certain immune cells in the low-risk group. Additionally, a correlation was found between higher risk scores and certain clinical characteristics. Knockdown of the P2RX4 gene was also observed to inhibit the proliferation of UCEC cells. In conclusion, these findings have the potential to improve targeted therapy and personalized medicine in UCEC patients through the use of this developed signature as a clinical prediction index.
Zhou, Chufan. et al. "The inflammatory response-related robust machine learning signature in endometrial cancer: Based on multi-cohort studies." The journal of gene medicine, 2023.
Pubmed:
37845174
DOI:
10.1002/jgm.3603